These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 15890579)

  • 1. Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer?
    Taghian AG; Assaad SI; Niemierko A; Floyd SR; Powell SN
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):386-91. PubMed ID: 15890579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation pneumonitis in breast cancer patients treated with taxanes: does sequential radiation therapy lower the risk?
    Beal K; Hudis C; Norton L; Wagman R; McCormick B
    Breast J; 2005; 11(5):317-20. PubMed ID: 16174151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer.
    Burstein HJ; Bellon JR; Galper S; Lu HM; Kuter I; Taghian AG; Wong J; Gelman R; Bunnell CA; Parker LM; Garber JE; Winer EP; Harris JR; Powell SN
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):496-504. PubMed ID: 16243442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer: cancer and leukemia group B 9344.
    Sartor CI; Peterson BL; Woolf S; Fitzgerald TJ; Laurie F; Turrisi AJ; Bogart J; Henderson IC; Norton L
    J Clin Oncol; 2005 Jan; 23(1):30-40. PubMed ID: 15545661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
    De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of radiotherapy after high-dose dense chemotherapy with epirubicin, preceded by dexrazoxane, and paclitaxel for patients with high-risk Stage II-III breast cancer.
    De Giorgi U; Giannini M; Frassineti L; Kopf B; Palazzi S; Giovannini N; Zumaglini F; Rosti G; Emiliani E; Marangolo M
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1165-9. PubMed ID: 16682141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: Dose-volume histogram analysis and comparison with conventional chemoradiation.
    Tsujino K; Hirota S; Kotani Y; Kado T; Yoden E; Fujii O; Soejima T; Adachi S; Takada Y
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1100-5. PubMed ID: 16373082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of radiation pneumonitis to treated lung volume in breast conservation therapy.
    Minor GI; Yashar CM; Spanos WJ; Jose BO; Silverman CL; Carrascosa LA; Farmer M; Paris KJ
    Breast J; 2006; 12(1):48-52. PubMed ID: 16409586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients.
    Yu TK; Whitman GJ; Thames HD; Buzdar AU; Strom EA; Perkins GH; Schechter NR; McNeese MD; Kau SW; Thomas ES; Hortobagyi GN; Buchholz TA
    J Natl Cancer Inst; 2004 Nov; 96(22):1676-81. PubMed ID: 15547180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma.
    Koh ES; Sun A; Tran TH; Tsang R; Pintilie M; Hodgson DC; Wells W; Heaton R; Gospodarowicz MK
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):223-8. PubMed ID: 16904523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
    Allen AM; Czerminska M; Jänne PA; Sugarbaker DJ; Bueno R; Harris JR; Court L; Baldini EH
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):640-5. PubMed ID: 16751058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy.
    Tsougos I; Mavroidis P; Rajala J; Theodorou K; Järvenpää R; Pitkänen MA; Holli K; Ojala AT; Lind BK; Hyödynmaa S; Kappas C
    Phys Med Biol; 2005 Aug; 50(15):3535-54. PubMed ID: 16030381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapy.
    Fox AM; Dosoretz AP; Mauch PM; Chen YH; Fisher DC; LaCasce AS; Freedman AS; Silver B; Ng AK
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):277-83. PubMed ID: 22019238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue.
    Lind PA; Marks LB; Jamieson TA; Carter DL; Vredenburgh JJ; Folz RJ; Prosnitz LR
    Cancer; 2002 Jun; 94(11):2821-9. PubMed ID: 12115368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy.
    Fay M; Tan A; Fisher R; Mac Manus M; Wirth A; Ball D
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1355-63. PubMed ID: 15817337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of hypothyroidism in older breast cancer patients treated with radiation.
    Smith GL; Smith BD; Giordano SH; Shih YC; Woodward WA; Strom EA; Perkins GH; Tereffe W; Yu TK; Buchholz TA
    Cancer; 2008 Mar; 112(6):1371-9. PubMed ID: 18213620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine prophylactic granulocyte colony stimulating factor (GCSF) is not necessary with accelerated (dose dense) paclitaxel for early breast cancer.
    Arnedos M; Sutherland S; Ashley S; Smith I
    Breast Cancer Res Treat; 2008 Nov; 112(1):1-4. PubMed ID: 18060493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of the Stockholm randomized trials of postoperative radiation therapy versus adjuvant chemotherapy among 'high risk' pre- and postmenopausal breast cancer patients.
    Rutqvist LE; Johansson H
    Acta Oncol; 2006; 45(5):517-27. PubMed ID: 16864164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
    Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
    J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients.
    Novakova-Jiresova A; Van Gameren MM; Coppes RP; Kampinga HH; Groen HJ
    Radiother Oncol; 2004 May; 71(2):183-9. PubMed ID: 15110452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.